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The addition reaction of a nucleophile to an 
N-acyliminium ion is a very efficient and valuable 
method for the synthesis of both a-substituted 
amides and s-substituted amines. This process, 
known for almost a century (Hellman, 1957), has 
been termed o~-amidoalkylation. The last decade 
has witnessed the development of various meth- 
ods of asymmetric syntheses on the basis of this 
reaction. These asymmetric syntheses employ 
three main strategies which differ mainly in the 
location of the chiral information eeded for the 
asymmetric induction. They can nicely be illus- 
trated by the synthesis of (-)-sedamine (3) which 
is a biologically active constituent of Sedum acre 
(Scheme 1). 
In one instance acyliminium ion precursors 
containing a chiral N-alkyl group which later 
becomes part of the final product (Irie et ah, 
1985) are used (see 1). This process corresponds 
to a chiral pool synthesis. In another more 
general approach the N-alkyl group also contains 
the chiral information, but this group is designed 
as a mere chiral auxiliary which consequently will 
be removed upon completion of the asymmetric 
synthesis (see 4) (Kiguchi et al., 1990). Finally, 
we ourselves relied on a concept wherein an 
N-acyl group represents the chiral auxiliary (see 
5). The first reagent we developed for this pur- 
pose is shown as 5 (Wanner and K~irtner, 1987). 
In this case the chiral auxiliary can easily be 
removed and the method as such may readily be 
applied to the preparation of a whole range of 
different nitrogen heterocycles. Recently others 
have also made use of this concept by employing 
carbamate-derived iminium ions as starting ma- 
terials (2) (Comins and Hong, 1993). 
As the above methods provide access to substi- 
tuted amines they appear to be of particular 
value in the synthesis of CNS-active compounds 
such as (-)-securinine (6). This compound (see 
Scheme 2) is representative of a small group of 
alkaloids produced by plants of the family 
Euphorbiaceae and is known to act as a CNS- 
stimulant and as a convulsive. Only recently it 
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has been found to be a GABAA-receptor an- 
tagonist acting at the GABA recognition site 
(Beutler and Brubaker, 1987). (-)-Securinine (6) 
with its unique ring skeleton thus appears to be a 
valuable lead for the development of new an- 
tagonists for the ligand binding site of the 
GABAA-receptor. We report herein on our at- 
tempts directed towards a total synthesis of (-)- 
securinine (6) and the preparation of compounds 
with corresponding substructures as potential 
ligands for the GABAA-receptor. 
In addition to the above studies we are also 
engaged in the asymmetric synthesis of 1-aryl 
substituted tetrahydroisoquinolines (8). In a re- 
cent paper, representatives of this class of com- 
pounds have been reported to be noncompetitive 
NMDA antagonists (ion channel site) (Gray et 
al., 1989). They are related to MK-801 (7) which 
is a selective blocker of the NMDA receptor- 
associated ion channel. Its binding is stereoselec- 
tive, the affinity of the (+)-enantiomer being 
seven times higher than that of the (-)-counter- 
part thereof (Wong et al., 1986). We wondered 
whether this was also true for the 1-aryl-iso- 
quinolines (8). The binding data that have been 
reported until now related to racemic material 
only (Gray et al., 1989). 
We chose compound (12) (Scheme 3) as key 
intermediate in our synthesis of securinine since 
we expected it to prove access both to the 
alkaloid and to substructures thereof. The 
homoallylic alcohol moiety was designated as  
synthetic precursor for the T-lactone subunit 
whereas the second double bond was intended to 
serve as branching point in our synthesis. On the 
one hand, the latter was to afford the ring 
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skeleton of the alkaloid by a ring closure reaction 
with the amine nitrogen also present in the 
molecule and, on the other hand, e.g., by cleav- 
age thereof, the double bond appeared to be 
useful in the preparation of derivatives of the 
natural product. The chiral amidoalkylation re- 
agent (9) served as starting point of our syn- 
thesis. The chiral auxiliary of (9) is derived from 
camphoric acid and the decisive step for 
stereodifferentiation in this case is precomplexa- 
tion (see 10) (Wanner and Painter, 1994). We 
tested various organometallic reagents such as 
nucleophiles in this reaction and most of them 
were found to add smoothly to (9) (after its 
activation with HCI) giving (11) in high yields 
and with satisfactory diastereoselectivity. By 
proceeding in the manner just described, we also 
were able to obtain an addition product (11) (for 
R see Scheme 3) which could be further pro- 
cessed to afford the intermediate (12). Our 
efforts are now directed towards the synthesis of 
securinine and of substructures thereof for bio- 
logical testing. 
The chiral auxiliary of (9) proved useful also in 
the synthesis of 1-aryl substituted isoquinolines 
(8) the stereoselectivity of the addition step 
(13----~ 14) reaching 95/5. We finally converted the 
corresponding addition products to the free tetra- 
hydroisoquinolines. Our next studies will concen- 
trate on their affinity for the ion-channel set of 
the NMDA receptor. 
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